Translational Development Acquisition Corp.
NASDAQ: TDACU0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Financial Services
- Industry
- Shell Companies
- CEO
- Michael Hoffman
- Employees
- 2
- Headquarters
- New York City, United States
- IPO year
- 2024
- Market cap
- $248.8M
- Website
- http://www.tridentacquisitions.com
Loading TDACU…
Loading profile data…Frequently asked questions about TDACU
What does Translational Development Acquisition Corp. (TDACU) do?
Translational Development Acquisition Corp. (TDACU) functions as a blank check entity, currently lacking any operational businesses or ventures of its own. Its sole purpose is to identify and complete a significant business combination, which could take the form of a merger, acquisition, asset purchase, share exchange, recapitalization, or other...
Where does TDACU trade?
Translational Development Acquisition Corp. (TDACU) trades on the NASDAQ Capital Market.
What sector is TDACU in?
Translational Development Acquisition Corp. (TDACU) operates in the Financial Services sector, specifically in the Shell Companies industry.
Who is the CEO of Translational Development Acquisition Corp.?
Michael Hoffman is the chief executive officer of Translational Development Acquisition Corp. (TDACU).
Where is Translational Development Acquisition Corp. headquartered?
Translational Development Acquisition Corp. is headquartered in United States.
Does TDACU pay a dividend?
Translational Development Acquisition Corp. (TDACU) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did TDACU go public?
Translational Development Acquisition Corp. (TDACU) completed its initial public offering in 2024.